186 related articles for article (PubMed ID: 26433958)
1. Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer.
Nowacka-Zawisza M; Forma E; Walczak M; Różański W; Bryś M; Krajewska WM
Med Oncol; 2015 Nov; 32(11):246. PubMed ID: 26433958
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.
Nowacka-Zawisza M; Bryś M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Cancer Detect Prev; 2008; 32(2):144-8. PubMed ID: 18632222
[TBL] [Abstract][Full Text] [Related]
3. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
[TBL] [Abstract][Full Text] [Related]
4. Genetic instability in the RAD51 and BRCA1 regions in breast cancer.
Nowacka-Zawisza M; Bryś M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Cell Mol Biol Lett; 2007; 12(2):192-205. PubMed ID: 17180310
[TBL] [Abstract][Full Text] [Related]
5. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH).
Schmutte C; Tombline G; Rhiem K; Sadoff MM; Schmutzler R; von Deimling A; Fishel R
Cancer Res; 1999 Sep; 59(18):4564-9. PubMed ID: 10493508
[TBL] [Abstract][Full Text] [Related]
8. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
[TBL] [Abstract][Full Text] [Related]
9. Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients.
Hampl JA; Hampl M; Reiss G; Koch R; Saeger HD; Schackert HK
Anticancer Res; 2004; 24(1):281-90. PubMed ID: 15015609
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.
Rio PG; Pernin D; Bay JO; Albuisson E; Kwiatkowski F; De Latour M; Bernard-Gallon DJ; Bignon YJ
Int J Oncol; 1998 Oct; 13(4):849-53. PubMed ID: 9735416
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer.
Uchida T; Wang C; Sato T; Gao J; Takashima R; Irie A; Ohori M; Koshiba K
Int J Cancer; 1999 Feb; 84(1):19-23. PubMed ID: 9988226
[TBL] [Abstract][Full Text] [Related]
12. [Genetic instability on chromosome 17q21 in gastric cancer of Chinese patients].
Lin XQ; Liang Y; Ding SP; Li JC
Shi Yan Sheng Wu Xue Bao; 2005 Apr; 38(2):148-56. PubMed ID: 16011248
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
14. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 in breast cancer.
Yang X; Lippman ME
Breast Cancer Res Treat; 1999 Mar; 54(1):1-10. PubMed ID: 10369075
[TBL] [Abstract][Full Text] [Related]
16. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
Eiriksdottir G; Johannesdottir G; Ingvarsson S; Björnsdottir IB; Jonasson JG; Agnarsson BA; Hallgrimsson J; Gudmundsson J; Egilsson V; Sigurdsson H; Barkardottir RB
Eur J Cancer; 1998 Dec; 34(13):2076-81. PubMed ID: 10070314
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer.
Prechtel D; Werenskiold AK; Prechtel K; Keller G; Höfler H
Diagn Mol Pathol; 1998 Feb; 7(1):57-62. PubMed ID: 9646036
[TBL] [Abstract][Full Text] [Related]
18. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D
Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282
[TBL] [Abstract][Full Text] [Related]
20. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]